Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history

Hereditary Cancer in Clinical Practice

Volumn 10, Issue 1, 2012, Pages

  Breitkopf, Carmen R ^a   Sinicrope, Pamela S ^a   Rabe, Kari G ^a   Brockman, Tabetha A ^a   Patten, Christi A ^a   McWilliams, Robert R ^a   Ehlers, Shawna ^a   Petersen, Gloria M ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Health behavior; Pancreatic cancer; Perceived risk; Screening intentions

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CANCER SCREENING; DEMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FALSE NEGATIVE RESULT; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PATIENT ATTITUDE;

EID: 84864753148     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-10-8     Document Type: Article

References (47)

1. American Cancer Society (ACS) Cancer Facts & Figures 2012 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf, American Cancer Society (ACS).
2. Hruban RH, Canto M, Goggins M, Schulick R, Klein AP. Update on Familial Pancreatic Cancer. Adv Surg 2010, 44:293-311. PMCID: PMC2966038, 2966038, 20919528.
3. Petersen GM, de Andrade M, Goggins M, Hruban RH, Bondy M, Korczak JF, Gallnger S, Lynch HT, Syngal S, Rabe KG, Seminara D, Klein AP. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006, 15:704-710. 15/4/70410.1158/1055-9965.EPI-05-0734, 16614112.
4. U.S. Preventive Services Task Force (USPSTF) Screening for Pancreatic Cancer: Recommendation Statement 2004, http://www.uspreventiveservicestaskforce.org/3rduspstf/pancreatic/pancrers.htm, U.S. Preventive Services Task Force (USPSTF).
5. Verna EC, Hwang C, Stevens PD, Rotterdam H, Stavropoulos SN, Sy CD, Prince MA, Chung WK, Fine RL, Chabot JA, Frucht H. Pancreatic cancer screening in a prospective cohort of high-risk patients: A comprehensive strategy of imaging and genetics. Clin Cancer Res 2010, 16:5028-5037. 10.1158/1078-0432.CCR-09-3209, 20876795.
6. Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: An eight-year experience. J Gastrointest Surg 2012, 16:771-783. 10.1007/s11605-011-1781-6, 22127781.
7. Goggins M, Canto M, Hruban R. Can we screen high-risk individuals to detect early pancreatic carcinoma?. J Surg Oncol 2000, 74:243-248. 10.1002/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C, 10962454.
8. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee J, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M, , . American Cancer of the Pancras Screening (CAPS) Consortium, American Cancer of the Pancras Screening (CAPS) Consortium Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterol 2012, 142:796-804. American Cancer of the Pancras Screening (CAPS) Consortium, American Cancer of the Pancras Screening (CAPS) Consortium.
9. Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI, , . Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas, Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007, 56:1460-1469. 10.1136/gut.2006.108456, 2000231, 17872573, Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas, Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas.
10. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Teo C, Fishman EK, Brune K, Axibund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN. Screening for early pancreatic neoplasia in high-risk individuals: a prosective controlled study. Clin Gastroenterol Hepatol 2006, 4:766-781. 10.1016/j.cgh.2006.02.005, 16682259.
11. Gold DV, Goggins M, Modrak DE, Newsome G, Liu M, Shi C, Hruban RH, Goldenberg DM. Detection of early-stage pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2010, 19:2786-2794. PMCID: PMC2976815, 10.1158/1055-9965.EPI-10-0667, 2976815, 20810605.
12. Li C, Zolotarevsky E, Thompson I, Anderson MN, Simeone DM, Casper JM, Mullenix MC, Lubman DM. A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer. Electrophoresis 2011, 32:2028-2035. 10.1002/elps.201000693, 21732554.
13. Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res 2011, 10:2359-2376. PMCID: PMC3090497, 10.1021/pr101148r, 3090497, 21443201.
14. Kisiel JB, Yab TC, Taylor WR, Chari ST, Petersen GM, Mahoney DW, Ahlquist DA. Stool DNA testing for the detection of pancreatic cancer: Identification and assessment of methylation marker candidates. Cancer 2012, 118:2623-2631. 10.1002/cncr.26558, 22083596.
15. Wiersema MJ. Accuracy of endoscopic ultrasound in diagnosing and staging pancreatic carcinoma. Pancreatology 2001, 1:625-632. 10.1159/000055872, 12120245.
16. Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jaqannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004, 2:606-621. 10.1016/S1542-3565(04)00244-7, 15224285.
17. Jhala NC, Jhala D, Eltoum I, Vickers SM, Wilcox CM, Chhieng DC, Eloubeidi MA. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a powerful tool to obtain samples from small lesions. Cancer 2004, 102:239-246. 10.1002/cncr.20451, 15368316.
18. Legmann P, Vignaux O, Dousset B, Baraza AJ, Palazzo L, Dumontier I, Coste J, Louvel A, Roseau G, Couturier D, Bonnin A. Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol 1998, 170:1315-1322.
19. Yasuda I, Iwashita T, Doi S, Nakashima M, Moriwaki H. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc 2011, 23(Suppl 1):22-25. 10.1111/j.1443-1661.2011.01113.x, 21535195.
20. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Griffin C, Cameron JL, Yeo CJ, Kern S, Hruban RH. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004, 64:2634-2638. 10.1158/0008-5472.CAN-03-3823, 15059921.
21. Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ Mariotto A, Miller BA, Feuer EJ, Altekruse SF, Lewis DR, Clegg L, Eisner MP, Reichman M, Edwards B. SEER Cancer Statistics Review, 1975-2005 2008, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER website.
22. Harinck F, Nagtegaal T, Kluijt I, Aalfs C, Smets E, Poley JW, Wagner A, van Hooft J, Fockens P, Bruno M, Bleiker EM. Feasibility of a pancreatic cancer surveillance program from a psychological point of view. Genet Med 2011, 13:1015-1024. 10.1097/GIM.0b013e31822934f5, 21857231.
23. Lampic C, Thurfjell E, Bergh J, Sjödén PO. Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 2001, 37:463-469. 10.1016/S0959-8049(00)00426-3, 11267855.
24. McCaul KD, Goetz PW. Worry: Health Behavior Constructs: Theory, Measurement, and Research Accessed from: http://dccps.cancer.gov/brp/constructs.worry/index.html. Accessed on June 28, 2012.
25. Michielutte R, Dignan MB, Smith BL. Psychosocial Factors Associated with the Use of Breast Cancer Screening by Women Age 60 Years or Over. Health Educ Behav 1999, 26:625-647. 10.1177/109019819902600505, 10533169.
26. Petersen GM, Larkin E, Codori AM, Wang CY, Booker SV, Bacon J, Giardiello FM, Boyd PA. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients. Cancer Epidemiol Biomarkers Prev 1999, 8:337-344.
27. Stefanek ME. Psychosocial aspects of breast cancer. Curr Opin Oncol 1992, 4:1055-1060. 10.1097/00001622-199212000-00009, 1457520.
28. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997, 89:1406-1422. 10.1093/jnci/89.19.1406, 9326910.
29. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:1455-1459. 16/7/145510.1158/1055-9965.EPI-07-0119, 17627010.
30. Lerman C, Rimer BK. Psychosocial impact of cancer screening. Psychosocial Effects of Screening for Disease Prevention and Detection 1995, 65-81. Oxford University Press, New York, Croyle RT.
31. Lerman C, Schwartz M. Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res Treat 1993, 28:145-155. 10.1007/BF00666427, 8173067.
32. Sinicrope PS, Rabe KG, Brockman TA, Patten CA, Petersen WO, Slusser J, Yang P, Swensen SJ, Edell ES, de Andrade M, Petersen GM. Perceptions of lung cancer risk and beliefs in screening accuracy of spiral computed tomography among high-risk lung cancer family members. Acad Radiol 2010, 17:1012-1025. 10.1016/j.acra.2010.04.003, 2897823, 20599157.
33. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet 2011, 378:607-620. 10.1007/s10897-008-9205-9, 21620466.
34. Lewis ZK, Frost CJ, Venne VL. Pancreatic cancer surveillance among high-risk populations: Knowledge and intent. J Genet Counsel 2009, 18:229-238.
35. Rogers RW. A protection motivation theory of fear appeals and attitude change. J Psychol 1975, 91:93-114.
36. Becker MH. The health belief model and personal health behavior. Health Educ Monogr 1974, 2:324-508.
37. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q 1988, 15:175-183. 10.1177/109019818801500203, 3378902.
38. Hay JL, Primavera LH, Levy A, Shuk E, Ostroff JS. Development and validation of a scale assessing novel cancer-related risk perceptions. Ann Behav Med 2006, 31:S190.
39. Hay JL, Shuk E, Cruz G, Ostroff J. Thinking Through Cancer Risk: Characerizing Smokers' Process of Risk Determination. Qualitative Health Res 2005, 15:1074-1085.
40. Jones SC, Magee CA, Barrie LR, Iverson DC, Gregory P, Hanks EL, Nelson AE, Nehill CL, Zorbas HM. Australian Women's Perceptions of Breast Cancer Risk Factors and the Risk of Developing Breast Cancer. Womens Health Issues 2011, 21:353-360. 10.1016/j.whi.2011.02.004, 21565527.
41. Mellon S, Berry-Bobovski L, Gold R, Levin N, Tainsky MA. Communication and decision-making about seeking inherited cancer risk information: Findings from female survivor-related focus groups. Psycho-Oncol 2006, 15:193-208.
42. Tilburt JC, James KM, Sinicrope PS, Eton DT, Costello BA, Carey J, Lane MA, Ehlers SL, Erwin PJ, Nowakowski KE, Murad MH. Factors Influencing Cancer Risk Perception in High Risk Populations: A Systematic Review. Hereditary Cancer Clin Pract 2011, 9:2. PMCID: PMC3118965.
43. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001, 286:921-929. 10.1001/jama.286.8.921, 11509056.
44. Boyle P, Maisonneuve P, Bueno de Mesquita B, Ghadirian P, Howe GR, Zatonski W, Baqhurst P, Moerman CJ, Simard A, Miller AB, Przewoniak K, McMichael AJ, Hsieh CC, Walker AM. Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC. Int J Cancer 1996, 67:63-71. 10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO;2-D, 8690527.
45. Perloff LS. Social comparison and illusions of invulnerability to negative life events. Coping with negative life events: Clinical and social psychological perspectives 1987, 217-242. Plenum Press, New York, NY, Snyder CR, Ford CE.
46. Perloff LS, Fetzer BK. Self-other judgments and perceived vulnerability to victimization. J Personality Social Psychol 1986, 50:502-510.
47. Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010, 28:4027-4037. 10.1016/j.vaccine.2010.03.063, 3006186, 20412875.